Jazz Pharmaceuticals PLC plans to buy drug maker Gentium SpA for roughly $1 billion in a cash deal aimed at expanding its rare disease drug portfolio.
http://www.pharmpro.com/news/2013/12/jazz-pharma-pay-1b-gentium-spa
http://www.pharmpro.com/news/2013/12/jazz-pharma-pay-1b-gentium-spa
No comments:
Post a Comment